Influenza vaccine safety data – Aboriginal and Torres Strait Islander participants (all ages)

Data on this page show the responses of Aboriginal and Torres Strait Islander people (or their parent/carer) who received an influenza vaccine in 2025 and completed an AusVaxSafety survey sent in the days following vaccination.

The influenza vaccines currently in use for Aboriginal and Torres Strait Islander people include:

Standard influenza vaccines

• Afluria Quad (individuals aged 5 years and older)
• Flucelvax Quad (individuals aged 6 months and older)
• FluQuadri (individuals aged 6 months and older)
• Influvac Tetra (individuals aged 6 months and older)
• Vaxigrip Tetra (individuals aged 6 months and older).

Adjuvanted or high-dose vaccines

• Fluad Quad (individuals aged 65 years and over)
• Fluzone High-Dose (individuals aged 60 years and over).

These data provide a profile of what to expect in the days following your influenza vaccination and can assist in planning for vaccination.

Data on this page will be updated weekly throughout the 2025 influenza season.
 

AusVaxSafety's active vaccine safety surveillance system complements the enhanced safety surveillance activities of the Therapeutic Goods Administration.

Further information and resources on the 2025 influenza vaccines are available on the NCIRS influenza immunisation webpage.